A phase 1 randomized open-label clinical study to evaluate the safety and tolerability of a novel recombinant hepatitis E vaccine.
about
A phase 1 randomized open-label clinical study to evaluate the safety and tolerability of a novel recombinant hepatitis E vaccine.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
A phase 1 randomized open-labe ...... combinant hepatitis E vaccine.
@en
type
label
A phase 1 randomized open-labe ...... combinant hepatitis E vaccine.
@en
prefLabel
A phase 1 randomized open-labe ...... combinant hepatitis E vaccine.
@en
P2093
P1433
P1476
A phase 1 randomized open-labe ...... combinant hepatitis E vaccine.
@en
P2093
Cheng-Bo Shi
Chun-Ping Chi
Feng-Cai Zhu
Ji-Hong Meng
Xin-Ping Wang
Yu-Feng Cao
Yue-Mei Hu
P304
P356
10.1016/J.VACCINE.2017.05.072
P407
P50
P577
2017-08-10T00:00:00Z